Barclays’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
Other funds holding INSM
BBA
Barclays's INSM Position: Q3 2026 in Review
Barclays reduced its Insmed (INSM) stake by 36% in Q3 2026, selling an estimated $7.87M and leaving 118,830 shares worth $13.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1476.
Barclays first reported a position in INSM in Q2 2013 and has held it in 53 quarters since. The position peaked at $77.4M in Q4 2025. 705 funds tracked by Wall St. Rank hold INSM as of Q3 2026.
- Barclays held 118,830 shares of Insmed worth $13.6M as of Q3 2026.
- Barclays sold 66,813 Insmed shares in Q3 2026, an estimated $7.87M.
- Insmed made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #1476 holding.
- Barclays first reported a position in Insmed in Q2 2013 and has held it in 53 quarters since.
- Barclays's Insmed position peaked at $77.4M in Q4 2025.
- 705 funds tracked by Wall St. Rank held Insmed as of Q3 2026.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.